"For 30 years, Western States Clinical Research (WSCR), Inc. has conducted clinical trials in a wide variety of therapeutic fields. Including, but not limited to: Dermatology, Gastroenterology & Hepatology, Allergies & Immunology, Ophthalmology, Respiratory Conditions, Cardiology, Rheumatology, Endocrinology and Women's Health. The study coordinators at WSCR, Inc. have a combined 55 years of clinical research experience and through continued education remain up to date in clinical research best practices and at the cusp of innovation in the research and development field. The principal investigator’s who work with WSCR, Inc are board-certified and experienced in their field of study."

During the past decade, Western States Clinical Research, Inc conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 8 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Western States Clinical Research, Inc" #1 sponsor was "Phathom Pharmaceuticals, Inc." with 4 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Celgene" with 2 trials sponsored, "Ellodi Pharmaceuticals, LP" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Western States Clinical Research, Inc" #1 collaborator was "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Western States Clinical Research, Inc" are "Eosinophilic Esophagitis" (4 trials), "Asthma" (2 trials), "COPD" (2 trials), "Crohn's Disease" (2 trials) and "Heartburn" (2 trials). Many other conditions were trialed in "Western States Clinical Research, Inc" in a lesser frequency.

Most popular intervention types in "Western States Clinical Research, Inc" are "Drug" (25 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Vonoprazan" (4 trials), "CC-93538" (2 trials), "Lansoprazole" (2 trials) and "APT-1011" (1 trials). Other intervention names were less common.

The vast majority of trials in "Western States Clinical Research, Inc" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Western States Clinical Research, Inc". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Western States Clinical Research, Inc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Western States Clinical Research, Inc, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".